Literature DB >> 32763197

Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder.

Jin Un Kim1, Amir Majid2, Rebekah Judge2, Peter Crook2, Rooshi Nathwani2, Nowlan Selvapatt2, James Lovendoski2, Pinelopi Manousou3, Mark Thursz4, Ameet Dhar3, Heather Lewis2, Nikhil Vergis3, Maud Lemoine3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32763197      PMCID: PMC7403133          DOI: 10.1016/S2468-1253(20)30251-X

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
We agree with the Editorial in the July, 2020, issue of The Lancet Gastroenterology & Hepatology, which emphasised the concerning long-term implications of lockdowns implemented to flatten the epidemic curve of COVID-19 on the health behaviour of individuals with alcohol-use disorder. A complex interplay of heightened financial difficulties, social isolation, uncertainty about the future, and the redistribution of the health workforce and the disruption to clinical services could contribute to increased alcohol intake and relapse under lockdown conditions, and, subsequently, contribute to further liver-associated complications via direct injury or through late presentations to the appropriate services.1, 2, 3, 4, 5 Lockdown is a complex social phenomenon that provokes different behavioural responses: a population survey of 1555 active drinkers in the UK identified that 21% increased alcohol consumption during the lockdown, while 35% reduced their alcohol intake. The true effect of the lockdown on alcohol intake remains unknown because of a paucity of qualitative data. 2 months after lockdown was declared in the UK (March 23, 2020), we did a cross-sectional telephone survey of patients with pre-existing alcohol disorders registered since 2017 in the alcohol clinic of St Mary's Hospital, London. From May 21 to June 10, 2020, 322 (70%) of 462 patients from the database were contacted and 182 (57%) agreed to participate (appendix). The survey was done in English using a standardised questionnaire by two trained clinicians (JUK, AM). Participants were mainly male (133 [73%] men, 49 [27%] women) and of white ethnicity (141 [78%]), with a median age of 57 years (IQR 49–66). 42 (23%) of the 182 participants were hazardous drinkers and 71 (39%) were moderate-severe alcohol users before lockdown, as assessed by AUDIT score. Of the 182 participants, 43 (24%) reported an increase in their alcohol intake, with a mean increase in the AUDIT score of 57·6%, and a mean weekly consumption of 82·5 units (SD 78). 34 (19%) reported a decrease in their alcohol intake. Although some parameters such as age, mood, and some social conditions differed between those who had increased, decreased, or had an unchanged consumption of alcohol during the lockdown (appendix), a multivariate analysis identified only the pre-lockdown AUDIT score and percentage change of AUDIT score from before to during lockdown as factors associated with increased alcohol intake during lockdown. 69 (38%) patients were classified as abstinent before lockdown, with a mean abstinence period of 19·5 months (SD 22). Of this subgroup, 12 (17%) relapsed during lockdown. Mean AUDIT score within the relapse group at the time of our survey was 15·7 (SD 9·6), representing a 226% mean increase from before lockdown, with a mean weekly consumption of 48·8 units (SD 63) during lockdown. Of the 113 individuals who were previously drinking before the lockdown, 14 (12%) became newly abstinent since the beginning of lockdown. Among all participants, 55 (30%) had either a virtual or face-to-face contact with the clinic during lockdown; 19 (44%) of the 43 individuals who had increased alcohol consumption had a clinic appointment, compared with 36 (26%) of the 139 individuals with decreased alcohol consumption or for whom consumption remained the same (p=0·035; odds ratio [OR] 0·586, 95% CI 0·378–0·908). Of the subgroup of patients who had a virtual or face-to-face consultation during the lockdown, 13 (24%) had contact specifically with an alcohol specialist nurse. Univariate analysis revealed that those who had contact with a specialist nurse were more likely to become newly abstinent, compared with those who did not have contact (two [100%] of two vs two [12%] of 17; p=0·035; OR 1·118, 95% CI 0·032–0·432); a positive trend was observed for reduced relapse during lockdown, occurring after alcohol nurse contact (six [18%] of 33 vs three [60%] of five; p=0·075; OR 0·303, 95% CI 0·110–0·839). We emphasise several points. First, lockdown causes different behavioural changes on alcohol intake, with about 20% of individuals increasing or decreasing their normal alcohol consumption. Although psychosocial distress has been well recognised as a risk of relapse and increased alcohol consumption, the reduction might be associated with decreased financial ability and the decreased availability of on-site alcohol areas (eg, pubs or bars). Second, we found no distinct protective factors for relapse, suggesting that pre-lockdown abstinence status is not protective against lockdown-related relapse. The mean duration of abstinence before relapse was long, which has been previously identified as a strong predictor of continuous abstinence. Lockdown might overshadow this paradigm. Third, those who relapsed had a clinically significant average level of alcohol consumption of nearly 49 units weekly post-relapse, which is concordant with previous studies of a high risk of harmful drinking after relapse. Finally, in a subgroup of patients who had clinical contact during lockdown, contact with an alcohol nurse specialist was a positive predictor for reducing relapse and improving new abstinence. Nonetheless, these findings should be interpreted with caution because of the small sample size of this subgroup. Our data represent a cross-sectional perspective of alcohol disorders during COVID-19 lockdown; any further changes that might present if lockdown conditions change remain to be elucidated. In summary, lockdown represents a risk factor for increasing alcohol consumption in people with alcohol use disorders and relapse for those who were previously abstinent. Those who do relapse are at a high risk of harmful drinking and require a tailored approach for follow-up and intervention. Support from alcohol liaison services could prevent relapse during lockdown.
  54 in total

1.  Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation.

Authors:  Andrew M Moon; Brenda Curtis; Pranoti Mandrekar; Ashwani K Singal; Elizabeth C Verna; Oren K Fix
Journal:  Hepatol Commun       Date:  2021-06-05

2.  Changes in alcohol use during COVID-19 and associations with contextual and individual difference variables: A systematic review and meta-analysis.

Authors:  Samuel F Acuff; Justin C Strickland; Jalie A Tucker; James G Murphy
Journal:  Psychol Addict Behav       Date:  2021-11-22

3.  Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.

Authors:  Thomas Marjot; Christiane S Eberhardt; Tobias Boettler; Luca S Belli; Marina Berenguer; Maria Buti; Rajiv Jalan; Mario U Mondelli; Richard Moreau; Daniel Shouval; Thomas Berg; Markus Cornberg
Journal:  J Hepatol       Date:  2022-07-20       Impact factor: 30.083

4.  Treatment seeking for alcohol-related issues during the COVID-19 pandemic: An analysis of an addiction-specialized psychiatric treatment facility.

Authors:  Mitchell J Andersson; Anders Håkansson
Journal:  Heliyon       Date:  2022-07-14

5.  Longitudinal predictors of depression, anxiety, and alcohol use following COVID-19-related stress.

Authors:  Lisa Venanzi; Lindsay Dickey; Haley Green; Samantha Pegg; Margaret M Benningfield; Alexandra H Bettis; Jennifer Urbano Blackford; Autumn Kujawa
Journal:  Stress Health       Date:  2022-01-10       Impact factor: 3.454

Review 6.  Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.

Authors:  Daniel Q Huang; Philippe Mathurin; Helena Cortez-Pinto; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-18       Impact factor: 73.082

7.  Change in modifiable dementia risk factors during COVID-19 lockdown: The experience of over 50s in Tasmania, Australia.

Authors:  Larissa Bartlett; James J R Brady; Maree Farrow; Sarang Kim; Aidan Bindoff; Hannah Fair; James C Vickers; Duncan Sinclair
Journal:  Alzheimers Dement (N Y)       Date:  2021-05-13

8.  COVID-19 lockdown may increase cardiovascular disease risk factors.

Authors:  Daha Garba Muhammad; Ibrahim Ahmad Abubakar
Journal:  Egypt Heart J       Date:  2021-01-05

Review 9.  Behavioral strategies to prevent and mitigate COVID-19 infection.

Authors:  Noah T Hutchinson; Andrew Steelman; Jeffrey A Woods
Journal:  Sports Med Health Sci       Date:  2020-09-10

10.  Longitudinal changes in anxiety and psychological distress, and associated risk and protective factors during the first three months of the COVID-19 pandemic in Germany.

Authors:  Antonia Bendau; Jens Plag; Stefanie Kunas; Sarah Wyka; Andreas Ströhle; Moritz Bruno Petzold
Journal:  Brain Behav       Date:  2020-11-23       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.